Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT05330429 · TERMINATED
Trial details
- NCT number
- NCT05330429
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2024-06-26
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.